Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Cormorant Capital
0
Cormorant Capital
Suggest edits
Overview
News
Investments
3
Portfolio
Portfolio Tracker
Add info
Xconomy
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia
Xconomy
BridgeBio's Pipeline Expansion Continues as Portfolio's Milestones Approach
Technical.ly Philly
University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO
PE HUB
VC-backed Cabaletta Bio begins trading on NASDAQ
Xconomy
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
PE HUB
Satsuma Pharmaceuticals goes public
Xconomy
BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut
MedCity News
BridgeBio files for $225M initial public offering
$299,200,000
Venture capital
PE HUB
BridgeBio Pharma racks up $299.2 mln
$50,000,000
Venture capital (Series B)
MedCity News
,
FinSMEs
Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies
Xconomy
BridgeBio Picks Up Novartis Cancer Drug, Launches New Biotech Startup
Health
Science
Xconomy
BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D
Health
Funding
$12,000,000
Venture capital (Series A)
PE Hub
Satsuma Pharmaceuticals takes in $12 mln Series A